Local definitive intensity-modulated radiation therapy recommended for patients initially diagnosed with nasopharyngeal carcinoma with distant metastasis after an effective systemic chemotherapy*
8 October 2018
? 2018 Huazhong University of Science and Technology
Nasopharyngeal carcinoma (NPC) is one of the most common head and neck cancers in southern China. In endemic areas, the NPC incidence is approximately 25–30 per 1?000?000 persons per year [1]. About 4% of patients are initially diagnosed with distant metastasis, especially those with locally advanced disease [2].
基金：
grants from Beijing Xisike Clinical Oncology Research Foundation(Y-Q201801-059)%CSCO-Merck Serono Oncology Research Fund(Y-MT2015-007)
语种：
外文
第一作者：
第一作者单位：[1]Cancer Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
通讯作者：
推荐引用方式(GB/T 7714)：
Lei Zhou,Dongbo Liu.Local definitive intensity-modulated radiation therapy recommended for patients initially diagnosed with nasopharyngeal carcinoma with distant metastasis after an effective systemic chemotherapy*[J].Oncology and Translational Medicine.2018,4(6):234-237.doi:10.1007/s10330-018-0294-4.
APA：
Lei Zhou&Dongbo Liu.(2018).Local definitive intensity-modulated radiation therapy recommended for patients initially diagnosed with nasopharyngeal carcinoma with distant metastasis after an effective systemic chemotherapy*.Oncology and Translational Medicine,4,(6)
MLA：
Lei Zhou,et al."Local definitive intensity-modulated radiation therapy recommended for patients initially diagnosed with nasopharyngeal carcinoma with distant metastasis after an effective systemic chemotherapy*".Oncology and Translational Medicine 4..6(2018):234-237
